segunda-feira, 16 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
News articleMIT Technology Review

A startup claims it’s found a drug to make your blood young

View original at technologyreview.com
MIT Technology Review - Ai Research Title: A startup claims it’s found a drug to make your blood young Date: 2026-08-27 19:48 Source: https://www.technologyreview.com/2026/08/27/1143037/startup-claims-its-found-a-drug-to-make-your-blood-young/ <div></div> <p>I knew I’d officially become a ‘longevity influencer’ this mo…
Opening lines of the source · MIT Technology Review · short snapshot: read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • There is a long wait list for the drug including celebrities and well-known people.

    60% confidence
  • AI will cure all disease within a few years.

    60% confidence
  • People, including high-end doctors, venture capitalists and biohackers, are clamoring for the drug.

    60% confidence
  • Matt Cook initially had zero confidence the drug combination would work because it consists of two safe, generic, non-longevity drugs.

    60% confidence
  • 1 Generation blocks the systemic spread of aging in the bloodstream, reawakens the body's own repair mechanism and restores health and youth to multiple tissues.

    60% confidence
  • Conboy's microfluidic testing system lets researchers ask which molecules can keep tissue young even when bathed in old blood serum.

    60% confidence
  • 1 Generation allows human cells to remain young even in the presence of old people's blood serum.

    60% confidence
  • After taking the injections, Cook experienced a surprising sense of mental clarity.

    60% confidence
  • The first longevity therapeutic to work in the human body is here and it's actually working.

    60% confidence
  • Subjects reported a broad set of symptoms and improvements that doesn't match what either underlying drug is known to do.

    60% confidence
  • Whether the drug combination will work is unknown, but there is enthusiasm based on Conboy's track record; Gladden is both skeptical and optimistic.

    60% confidence
  • In the battle between old and young blood, old blood dominates.

    60% confidence

Citado nestas reportagens da Via News